Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink
Anna E. Denoble(Yale University), Heather S. Lipkind(Cornell University), Darios Getahun(Kaiser Permanente), Matthew F. Daley(Kaiser Permanente), Sangini S. Sheth(Centers for Disease Control and Prevention), Jingyi Zhu, Christina M. Ackerman‐Banks(Baylor College of Medicine), James G. Donahue(Brigham and Women's Hospital), Nicola P. Klein, Malini B. DeSilva(HealthPartners), Jennifer C. Nelson(Kaiser Permanente Washington Health Research Institute), Elyse O. Kharbanda(HealthPartners), Stephanie A. Irving(Kaiser Permanente Center for Health Research), Eric Weintraub, Simon J. Hambidge, Joshua T.B. Williams(Denver Health Medical Center), Gabriela Vazquez‐Benitez, Kimberly K. Vesco(Kaiser Permanente)
Cited by 9
Related Papers
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
SARS–CoV-2 infection of the placenta
|Journal of Clinical Investigation|2020|492